CN Stock MarketDetailed Quotes
300016 Beijing Beilu Pharmaceutical
- 6.23
- +0.12+1.96%
Market Closed Oct 18 15:00 CST
3.06BMarket Cap-49444P/E (TTM)
6.33High6.07Low218.90KlotVolume6.07Open6.11Pre Close135.47MTurnover4.46%Turnover RatioLossP/E (Static)491.94MShares8.9352wk High1.97P/B3.06BFloat Cap3.5852wk Low7.33Limit Up491.18MShs Float43.97Historical High4.89Limit Down4.26%Amplitude1.91Historical Low--Dividend TTM6.19Avg Price98.42KlotAsk--Div YieldTTM100Lot Size118.17KlotBid
Beijing Beilu Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 8.20%473.93M | 10.35%207.51M | 16.30%890.72M | 16.60%649.82M | 24.70%438.03M | 2.23%188.04M | -10.93%765.88M | -18.14%557.31M | -34.38%351.26M | -17.18%183.93M |
| Operating revenue | 8.20%473.93M | 10.35%207.51M | 16.30%890.72M | 16.60%649.82M | 24.70%438.03M | 2.23%188.04M | -10.93%765.88M | -18.14%557.31M | -34.38%351.26M | -17.18%183.93M |
| Other operating revenue | 313.48%3.57M | ---- | 44.96%6.42M | ---- | -58.00%864.44K | ---- | 44.69%4.43M | ---- | 89.79%2.06M | ---- |
| Total operating cost | 1.74%452.06M | 5.58%191.5M | 19.91%947.67M | 24.16%675.05M | 33.75%444.33M | 21.20%181.38M | 2.25%790.34M | -4.24%543.7M | -20.39%332.2M | -13.96%149.65M |
| Operating cost | 5.67%233.59M | -6.45%92.11M | 38.15%472.01M | 44.72%331.88M | 55.04%221.05M | 34.66%98.45M | 5.31%341.66M | -4.61%229.32M | -27.26%142.58M | -11.95%73.11M |
| Operating tax surcharges | 8.74%6.17M | 49.61%2.69M | -10.15%10.29M | 10.22%8.51M | 7.29%5.68M | -25.30%1.8M | 11.04%11.45M | 1.78%7.72M | -18.04%5.29M | -6.59%2.41M |
| Operating expense | 10.50%112.93M | 52.54%52.05M | 3.08%217.05M | 4.44%154.42M | 16.57%102.2M | -12.18%34.12M | -26.03%210.56M | -30.29%147.86M | -37.22%87.67M | -21.47%38.85M |
| Administration expense | 6.66%39.15M | 1.25%18.05M | -4.61%81.74M | -15.07%55.51M | -5.26%36.71M | -6.55%17.82M | 8.54%85.69M | 19.13%65.36M | 3.86%38.75M | 1.52%19.07M |
| Financial expense | -0.93%24.77M | 4.78%12.72M | 5.43%44.26M | 32.98%38.38M | 38.91%25M | 38.93%12.14M | 53.22%41.98M | 40.07%28.86M | 32.58%18M | 48.76%8.74M |
| -Interest expense (Financial expense) | 10.94%28.16M | 10.00%13.76M | 11.53%53.14M | 12.81%39.66M | 11.11%25.38M | 13.07%12.51M | 7.82%47.64M | 8.47%35.16M | 5.55%22.84M | 3.77%11.06M |
| -Interest Income (Financial expense) | 21.61%-3.39M | 35.24%-1.68M | -39.34%-11.82M | -11.01%-6.68M | -7.43%-4.32M | -37.90%-2.6M | 35.71%-8.48M | 39.39%-6.02M | 37.36%-4.02M | 32.18%-1.88M |
| Research and development | -33.98%35.45M | -18.50%13.89M | 23.55%122.33M | 33.70%86.35M | 34.51%53.7M | 128.07%17.04M | 109.64%99.01M | 100.45%64.58M | 64.21%39.92M | -47.36%7.47M |
| Credit Impairment Loss | 133.17%566.92K | 143.39%879.63K | -598.64%-3.83M | -226.30%-1.76M | -202.20%-1.71M | -64.45%361.41K | -42.19%768.89K | 96.06%1.39M | 140.56%1.67M | 307.61%1.02M |
| Asset Impairment Loss | 6.10%-3.22M | -34.34%-834.08K | -89.72%-45.18M | -25.60%-3.75M | -215.35%-3.43M | 66.55%-620.86K | -572.32%-23.81M | -108.25%-2.99M | -0.34%-1.09M | -78.33%-1.86M |
| Other net revenue | -115.10%-1.27M | -103.84%-139.04K | -489.15%-43.49M | -45.72%15.49M | -55.68%8.41M | -36.81%3.62M | -72.23%11.18M | 1.60%28.54M | 105.49%18.98M | 27.59%5.74M |
| Fair value change income | -236.13%-8.91M | -229.90%-3.68M | -153.19%-13.96M | -56.54%9.19M | -49.60%6.54M | -43.54%2.84M | 88.78%26.24M | 124.23%21.15M | 124.64%12.98M | 8.68%5.02M |
| Invest income | 4.16%3.78M | 530.08%849.8K | 205.20%5.99M | 264.67%4.51M | 192.70%3.63M | -150.05%-197.59K | -143.39%-5.7M | -160.91%-2.74M | -175.95%-3.91M | 93.37%394.8K |
| -Including: Investment income associates | -70.70%330.16K | 53.16%-371.13K | 117.23%1.95M | 185.91%1.7M | 152.80%1.13M | -10,627.56%-792.28K | -585.00%-11.35M | -240.81%-1.98M | -245.41%-2.13M | -102.77%-7.39K |
| Asset deal income | -99.79%1.82K | --1.82K | 801.04%894.31K | 772.62%866.11K | --866.11K | ---- | -21.32%99.25K | -21.32%99.25K | ---- | ---- |
| Other revenue | 158.83%6.51M | 112.50%2.65M | -7.27%12.59M | -44.70%6.43M | -73.03%2.52M | 7.54%1.25M | -11.30%13.58M | -21.23%11.62M | 165.57%9.33M | -3.50%1.16M |
| Operating profit | 874.88%20.6M | 54.28%15.86M | -656.17%-100.44M | -123.10%-9.74M | -94.44%2.11M | -74.30%10.28M | -110.44%-13.28M | -70.14%42.15M | -70.10%38.04M | -23.97%40.01M |
| Add:Non operating Income | -93.32%100.53K | 92.12%49.32K | 386.71%1.77M | 3,896.51%1.52M | 3,858.83%1.5M | 25,570.58%25.67K | 31.74%363.23K | -85.89%37.99K | -78.10%37.99K | -93.34%100 |
| Less:Non operating expense | -51.01%266.21K | -88.33%3.71K | 34.81%2.48M | -41.90%811.19K | -29.80%543.44K | -94.07%31.83K | -63.84%1.84M | -67.83%1.4M | -77.36%774.19K | 60.71%536.46K |
| Total profit | 564.83%20.44M | 54.82%15.91M | -585.25%-101.15M | -122.14%-9.03M | -91.76%3.07M | -73.97%10.28M | -112.06%-14.76M | -70.24%40.79M | -69.91%37.3M | -24.51%39.48M |
| Less:Income tax cost | 378.17%5.24M | 4,586.93%4.29M | -75.80%-17.95M | -253.02%-4.81M | -164.74%-1.88M | -98.05%91.47K | -184.67%-10.21M | -109.09%-1.36M | -80.19%2.91M | -32.56%4.7M |
| Net profit | 206.69%15.2M | 14.11%11.62M | FPtoL-83.2M | SL-4.21M | -85.59%4.96M | -70.72%10.18M | SL-4.55M | -65.47%42.15M | -68.53%34.4M | -23.27%34.78M |
| Net profit from continuing operation | 206.69%15.2M | 14.11%11.62M | -1,728.99%-83.2M | -110.00%-4.21M | -85.59%4.96M | -70.72%10.18M | -104.12%-4.55M | -65.47%42.15M | -68.53%34.4M | -23.27%34.78M |
| Less:Minority Profit | 6.54%-4.34M | 103.97%95.08K | 27.72%-11.44M | 52.87%-6.16M | 17.80%-4.65M | 46.69%-2.39M | -4.02%-15.83M | -70.25%-13.06M | 21.35%-5.65M | 12.47%-4.49M |
| Net profit of parent company owners | 103.52%19.54M | -8.35%11.53M | -735.92%-71.76M | -96.48%1.94M | -76.02%9.6M | -67.97%12.58M | -91.01%11.28M | -57.44%55.21M | -65.62%40.05M | -22.18%39.26M |
| Earning per share | ||||||||||
| Basic earning per share | 100.00%0.04 | -8.20%0.0235 | -850.00%-0.15 | -96.44%0.004 | -75.00%0.02 | -68.00%0.0256 | -92.31%0.02 | -57.60%0.1125 | -66.67%0.08 | -22.48%0.08 |
| Diluted earning per share | 40.00%0.07 | -0.95%0.0415 | -187.50%-0.07 | -64.17%0.0535 | -54.55%0.05 | -49.58%0.0419 | -71.43%0.08 | -47.85%0.1493 | -56.00%0.11 | -27.36%0.0831 |
| Other composite income | ||||||||||
| Total composite income | 206.69%15.2M | 14.11%11.62M | -1,728.99%-83.2M | -110.00%-4.21M | -85.59%4.96M | -70.72%10.18M | -104.15%-4.55M | -65.45%42.15M | -68.52%34.4M | -23.24%34.78M |
| Total composite income of parent company owners | 103.52%19.54M | -8.35%11.53M | -735.92%-71.76M | -96.48%1.94M | -76.02%9.6M | -67.97%12.58M | -90.96%11.28M | -57.42%55.21M | -65.61%40.05M | -22.14%39.26M |
| Total composite income of minority owners | 6.54%-4.34M | 103.97%95.08K | 27.72%-11.44M | 52.87%-6.16M | 17.80%-4.65M | 46.69%-2.39M | -4.02%-15.83M | -70.25%-13.06M | 21.35%-5.65M | 12.47%-4.49M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data